Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease, and 25% to 70% of patients with longstanding PsA have axial involvement, which can lead to worsened outcomes and even potentially permanent joint and spine damage. In this article, Dr Micaela F. Bayard, assistant professor of rheumatology at the Icahn School of Medicine at Mount Sinai in New York City, discusses methods to screen for and treat axial involvement in patients with PsA.
Special Collections
